Journal article · 2026

Ethical challenges in patient-focused drug development for rare genetic diseases

Meghan C. Halley, Matthew S. McCoy

Nature Genetics · Published 30 October 2026 · DOI 10.1038/s41588-026-02824-3

View at the publisherCite this paper

In brief

“Ethical challenges in patient-focused drug development for rare genetic diseases” is a 2026 journal article by Meghan C. Halley and Matthew S. McCoy, published in Nature Genetics. OpenAlex counts 0 citations as of 17 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
13
Authors
2

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Halley, M. C., & McCoy, M. S. (2026). Ethical challenges in patient-focused drug development for rare genetic diseases. Nature Genetics. https://doi.org/10.1038/s41588-026-02824-3

MLA 9

Halley, Meghan C., and Matthew S. McCoy. “Ethical challenges in patient-focused drug development for rare genetic diseases.” Nature Genetics, 2026. https://doi.org/10.1038/s41588-026-02824-3.

Chicago

Halley, Meghan C. and Matthew S. McCoy. 2026. “Ethical challenges in patient-focused drug development for rare genetic diseases.” Nature Genetics. https://doi.org/10.1038/s41588-026-02824-3.

Harvard

Halley, M. C. and McCoy, M. S. (2026) ‘Ethical challenges in patient-focused drug development for rare genetic diseases’, Nature Genetics. doi:10.1038/s41588-026-02824-3.

IEEE

M. C. Halley and M. S. McCoy, “Ethical challenges in patient-focused drug development for rare genetic diseases,” Nature Genetics, 2026, doi: 10.1038/s41588-026-02824-3.

BibTeX

@article{halley2026ethical,
  title     = {{Ethical challenges in patient-focused drug development for rare genetic diseases}},
  author    = {Halley, Meghan C. and McCoy, Matthew S.},
  journal   = {Nature Genetics},
  year      = {2026},
  doi       = {10.1038/s41588-026-02824-3},
  url       = {https://doi.org/10.1038/s41588-026-02824-3}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation

  • rare genetic disorders
  • patient-focused drug development
  • patient and family involvement
  • clinical trial design
  • regulatory strategy
  • research ethics
  • industry partnerships
  • university-industry collaboration

Work with this paper

Most-cited papers in Nursing

All highly cited Nursing papers

Questions about this paper

How do I cite this paper in APA style?

Halley, M. C., & McCoy, M. S. (2026). Ethical challenges in patient-focused drug development for rare genetic diseases. Nature Genetics. https://doi.org/10.1038/s41588-026-02824-3

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Meghan C. Halley, Matthew S. McCoy.

What is the DOI of this paper?

10.1038/s41588-026-02824-3, permanently at https://doi.org/10.1038/s41588-026-02824-3. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.